Lack of p53 Nuclear Immunostaining Is Not Indicative of Absence of TP53 Gene Mutations in Colorectal Adenocarcinomas

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Applied immunohistochemistry & molecular morphology (Print)

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00129039-200306000-00007PMID 12777996
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gain-of-function mutations in the tumor suppressor gene p53.

  2000cited by this paper
• Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

  1999cited by this paper
• Evaluation of multiple bio‐pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl‐2

  1999cited by this paper
• Clinical implications of p53 mutations

  1999cited by this paper
• The p53 tumour suppressor gene

  1998cited by this paper
• Chromosome 18q allelic loss and prognosis in stage II and III colon cancer

  1998cited by this paper
• Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.

  1998cited by this paper
• Comparative Survival Analysis of p53 Gene Mutations and Protein Accumulation in Colorectal Cancer

  1998cited by this paper
• Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma.

  1997cited by this paper
• Apoptosis and cancer chemotherapy.

  1996cited by this paper
• Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.

  1996cited by this paper
• Apoptosis and cancer chemotherapy.

  1994cited by this paper
• Prognostic relevance of p53 mutation in colorectal carcinoma

  1994cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994influential reference
• Association of p53 mutations with short survival in colorectal cancer.

  1994cited by this paper
• Altered patterns of MDM2 and TP53 expression in human bladder cancer.

  1994cited by this paper
• A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma.

  1994cited by this paper
• p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns

  1994cited by this paper
• Clinical implications of the p53 tumor-suppressor gene.

  1994cited by this paper
• TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus.

  1994cited by this paper
• The rapid detection of unknown mutations in nucleic acids

  1993cited by this paper
• Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers.

  1993cited by this paper
• Gain of function mutations in p53

  1993cited by this paper
• Clinical implications of the p53 tumor-suppressor gene.

  1993cited by this paper
• Expression of p53 and 17p allelic loss in colorectal carcinoma.

  1992cited by this paper
• Survival and acquired genetic alterations in colorectal cancer.

  1992cited by this paper
• Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism

  1992cited by this paper
• Tumor suppressor p53: analysis of wild-type and mutant p53 complexes

  1991cited by this paper
• PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA.

  1991cited by this paper
• Genital human papillomavirus infection in female university students as determined by a PCR‐based method

  1991cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.

  1990cited by this paper
• p53 mutations in colorectal cancer.

  1990cited by this paper
• p53: oncogene or anti-oncogene?

  1990cited by this paper
• Increased expression of mutant forms of p53 oncogene in primary lung cancer.

  1990cited by this paper
• p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

  1990cited by this paper
• 從致癌基因（Oncogene）到抗致癌基因（Anti-oncogene）

  1989cited by this paper
• Wild-type p53 can inhibit oncogene-mediated focus formation.

  1989cited by this paper
• Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

  1989cited by this paper
• Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

  1989cited by this paper
• Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected].

  1989cited by this paper
• Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation

  1989cited by this paper
• TNM atlas : illustrated guide to the TNM/pTNM-classification of malignant tumours

  1989cited by this paper
• Allelic Loss in Colorectal Carcinoma

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis.

  1988cited by this paper
• A multivariate analysis of pathologic prognostic indicators in large bowel cancer

  1988cited by this paper
• Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction

  1988cited by this paper
• Biases in the assessment of diagnostic tests.

  1987cited by this paper
• Functional inactivation of genes by dominant negative mutations

  1987cited by this paper
• Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

  1986cited by this paper
• The meaning and use of the area under a receiver operating characteristic (ROC) curve.

  1982cited by this paper
• The relationship of survival to staging and grading of colorectal carcinoma: A prospective study of 503 cases

  1981cited by this paper

• The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer

  2022cites this paper
• SPATA18 Expression Predicts Favorable Clinical Outcome in Colorectal Cancer

  2022cites this paper
• Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study

  2020cites this paper
• Changes of Genetic Loci among Gastric Cancer Patients, Southeastern Iran, 2017

  2020cites this paper
• Quantitative evaluation of TP53 immunohistochemistry to predict gene mutations: lessons learnt from a series of colorectal carcinomas.

  2019cites this paper
• Dedifferentiation in SDH-Deficient Gastrointestinal Stromal Tumor: A Report With Histologic, Immunophenotypic, and Molecular Characterization

  2019cites this paper
• P53 Expression In Colorectal Epithelial Neoplasms And Its Relation To Clinical And Histopathological Features

  2018cites this paper
• TP53 mutations in p53-negative dysplastic urothelial cells from Belgian AAN patients: New evidence for aristolochic acid-induced molecular pathogenesis and carcinogenesis.

  2017cites this paper
• Predicting malignancy in pre-neoplastic lesions detected during screening for pancreatic cancer

  2017cites this paper
• Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer

  2015cites this paper
• Clinical and pathological correlations of marrow PUMA and P53 expressions in myelodysplastic syndromes

  2015cites this paper
• p53 in the Clinic: A Pathologist’s View

  2013cites this paper
• Household Income Is Associated with the p53 Mutation Frequency in Human Breast Tumors

  2013cites this paper
• Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms.

  2013cites this paper
• Sobreexpresión de p53 como factor pronóstico en niños con astrocitomas p53 overexpression prognostic factor in children with astrocytoma

  2011cites this paper
• p53-Alterationen in Kolonadenomen: Beziehung zu Zellproliferation und Klinik

  2011cites this paper
• Clinicopathological and molecular characterization of colorectal micropapillary carcinoma

  2011cites this paper
• p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.

  2008cites this paper
• Expression of p53 in colorectal carcinoma: correlation with clinicopathologic features.

  2007cites this paper
• Detection of P53 exon 6 mutions in colorectal cancer patients by PCR-SSCP method in Isfahan Hospital during 2004 -2005

  2006cites this paper
• Association of breast cancer outcome with status of p53 and MDM2 SNP309.

  2006cites this paper
• برسی فراوانی جهش اکسون 6 ژن P53 با روش PCR-SSCP در بیماران مبتلا به سرطان کولورکتال مراجعهکننده به بیمارستانهای اصفهان در طی سالهای 1382 الی 1384

  2006cites this paper
• Chemotherapeutic Strategies with Microsatellite Instability : Implications for High Thymidylate Synthase Expression in Colorectal Cancer

  2005cites this paper
• High Thymidylate Synthase Expression in Colorectal Cancer with Microsatellite Instability: Implications for Chemotherapeutic Strategies

  2005cites this paper
• Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab.

  2005cites this paper
• A Novel Logistic Model Based on Clinicopathological Features Predicts Microsatellite Instability in Colorectal Carcinomas

  2005cites this paper